RE: correct reporting is of utmost importance when a controversial treatment is being evaluated

HPB (Oxford). 2019 Sep;21(9):1251-1252. doi: 10.1016/j.hpb.2019.04.009. Epub 2019 May 17.

Authors

Urban Arnelo¹, Elena Rangelova¹, Marco Del Chiaro², Roberto Valente¹, Caroline Verbeke³

Affiliations

¹ Division of Surgery, CLINTEC, Karolinska Institute, Stockholm, Sweden.
² Division of Surgery, CLINTEC, Karolinska Institute, Stockholm, Sweden; Division of Surgical Oncology, Department of Surgery, University of Colorado Anschutz Medical Campus, Denver, CO, USA. Electronic address: marco.delchiaro@ucdenver.edu.
³ Department of Pathology, Oslo University, Oslo, Norway.

PMID: 31109873
DOI: 10.1016/j.hpb.2019.04.009

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Palliative Care
Pancreatectomy*
Pancreatic Neoplasms* / surgery
Treatment Outcome